Kaprex® Selective Kinase Response Modulators for Worry-Free Joint Relief

Recommendations: One softgel two times daily with food or as directed by your healthcare practitioner.
Form: 20 Softgel Bottle (New & Improved); 60 Softgel Bottle (New & Improved)

Product Description:

Kaprex provides a safer option for effective joint relief. This proprietary combination of selected plant components influences kinase signaling and the formation of certain substances that are associated with minor pain. Clinical testing suggests that Kaprex may offer a high degree of predicted cardiovascular, gastric, renal, and liver safety.

• Provides effective joint relief that is worry-free.
• Modulates prostaglandin E₂ (PGE₂) production at specific target cells.
• Features SKRMs in the form of THIAA to modulate kinase activity in favor of good health.
• The ingredient synergy of Tetrase™, oleanolic acid, and rosemary provide efficacy at a low dose for a maximum cost-effectiveness.
• Developed through the ExpresSyn™ Process, which combines cell proteomic research, safety evaluations, human ex vivo research, and clinical testing for maximum safety and effectiveness.

EACH SOFTGEL SUPPLIES:
A proprietary blend of:	350 mg
Tetrase™, (Tetrahydro-iso-alpha acids complex†, from hops) (Humulus lupulus L.), Oleanolic Acid (from olive leaf extract, Olea europaea), Rosemary Leaf Extract (Rosmarinus officinalis)
Other Ingredients: Soybean oil , gelatin, glycerin, lecithin (soy), water, beeswax, and sodium copper chlorophyllin. Contains: soy.

ADDITIONAL PRODUCT INFORMATION: Doctor Brochure: Kaprex® Doctor Brochure: Kaprex® & Kaprex® AI Doctor Brochure: Kaprex® Prescriber Info Sheet

Requires Adobe Acrobat Reader.

These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat cure, or prevent any diseases.